肝病用藥
這類藥物主要用于治療肝炎、肝硬化及肝性腦病等肝臟疾病。盡管目前許多肝病，尤其是病毒性肝炎尚無特效療法，某些必需氨基酸或其他參與正常生化過程的物質僅可作為輔助用藥，并且其確切療效仍需進一步驗證。需要注意的是，在正常人體內并不缺乏這些物質，因此不可隨意濫用，以免加重肝臟代謝負擔。
研究表明，許多病毒性肝炎、原發性膽汁性肝硬化和硬化性膽管炎等疾病可能與自身免疫機制有關，相應的免疫抑制劑及免疫功能調節藥物可參考相關章節。目前多數觀點認為肝性腦病的發病機制可能與血氨水平升高或腦內神經遞質異常有關，因此治療肝性腦病的主要藥物包括降血氨和糾正中樞神經系統功能紊亂的藥物。
隨著對促肝細胞生長物質基礎研究的深入及其在臨床應用中的不斷推廣，這些生物制品也被納入其中。
| 中文名稱 | 英文名稱 | CAS號 | 化學式 |
|---|---|---|---|
| 齊墩果酸 | Oleanolic acid | 508-02-1 | C30H48O3 |
| 阿卡明 | Orazamide orotate | 7425-69-6 | C4H6N4O*C5H4N2O4 |
| 聯苯雙酯 | DDB | 73536-69-3 | C20H18O10 |
| 美他多辛、焦谷氨酸鹽 | Metadoxine | 74536-44-0 | C13H18N2O6 |
| 紫草素 | (S)-5,8-dihydroxy-2-(1-hydroxy-4-methylpent-3-enyl)naphthalene-1,4-dione | 517-88-4 | C16H16O5 |
| 紫朱牛舌草(ALKANNATINCTORIA)根提取物 | shikonin | 85251-58-7 | C16H16O5 |
| 硫普羅寧 | N-(2-mercaptopropionyl)glycine | 1953-02-2 | C5H9NO3S |
| 甘草酸銨 | triazanium;(2S,3S,4S,5R,6R)-6-[(2S,3R,4S,5S,6S)-2-[[(3S,4aR,6aR,6bS,8aS,11S,12aR,14aR,14bS)-11-carboxylato-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1H-picen-3-yl]oxy]-6-carboxylato-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate | 68083-53-4 | C42H71N3O16 |
| 甘草酸銨 | ammonium glycyrrhizinate | 53956-04-0 | C42H62O16*H3N |
| 甘草酸 | glycyrrhizin | 1405-86-3 | C42H62O16 |
| 原卟啉 | Protoporphyrin IX | 553-12-8 | C34H34N4O4 |
| 二氯醋酸二異丙胺 | Diisopropylamin-dichloracetat | 660-27-5 | C2H2Cl2O2*C6H15N |
| 二異丙胺 | diisopropylamine | 108-18-9 | C6H15N |
| 二噻茂醋 | diisopropyl 2-(1,3-dithiol-2-ylidene)malonate | 59937-28-9 | C12H16O4S2 |
| 18Α-甘草酸銨鹽 | 18α-Glycyrrhizic Acid Ammonium Salt | 53956-04-0 | C42H62O16*H3N |
| —— | potassium;6-[(11-carboxy-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1H-picen-3-yl)oxy]-5-(6-carboxy-3,4,5-trihydroxyoxan-2-yl)oxy-3,4-dihydroxyoxane-2-carboxylate | 68039-19-0 | C42H61KO16 |
| —— | alpha-D-Glucopyranosiduronic acid, (3beta,20beta)-20-carboxy-11-oxo-30-norolean-12-en-3-yl 2-O-beta-D-glucopyranuronosyl-, monopotassium salt | 68797-35-3 | C42H62KO16 |
| —— | β-Glycyrrhicic acid tripotassium salt | 42294-03-1 | C42H59O16*3K |
| —— | α-d-Glucopyranosiduronic acid, (3beta,20beta)-20-carboxy-11-oxo-30-norolean-12-en-3-yl 2-O-β-d-glucopyranuronosyl-, monopotassium salt | 42294-03-1 | C42H61O16*K |
| —— | lipoate | 62-46-4 | C8H13O2S2 |
| —— | 58-dihydroxy-2-[(1S)-1-hydroxy-4-methylpent-3-enyl]naphthalene-14-dione | 23444-65-7 | C16H16O5 |
| —— | 6-[2-[[(6aR,6bS,8aS,11S,14bS)-11-carboxy-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1H-picen-3-yl]oxy]-6-carboxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid | 1405-86-3 | C42H62O16 |
| —— | (2S,3S,4S,5R,6R)-6-[(2S,3R,4S,5S,6S)-2-[[(3S,6Ar,6bS,8aS,11S,12aR,14aR,14bS)-11-carboxy-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1H-picen-3-yl]oxy]-6-carboxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid | 1405-86-3 | C42H62O16 |
| —— | glycyrrhetinic acid | 1405-86-3 | C42H62O16 |
| —— | oleanoic acid | 508-02-1 | C30H48O3 |
| —— | Palepron | 50865-01-5 | C34H34N4NaO4+ |
| —— | Liquorice | 1405-86-3 | C42H62O16 |
聯系我們
關注我們
公眾號
